Rabbit Polyclonal Cytochrome P450 2C9 CYP2C9 Antibody (Human)

<strong>Rabbit Polyclonal Cytochrome P450 2C9 CYP2C9 Antibody (Human)</strong> <strong>Catalog number:</strong> B2023878 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 55.628 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Rabbit Polyclonal CYP2C9 Antibody, Rabbit Anti-Cytochrome P450 2C9 Antibody, Anti-CYP2C9 Antibody, Rabbit Anti-Cytochrome P450 2C9, Polyclonal Rabbit CYP2C9 Antibody, Rabbit Polyclonal Anti-Cytochrome P450 2C9, Human CYP2C9 Antibody, Rabbit Anti-Human CYP2C9 Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kuehl, P. et al. (2001). "Genetic polymorphisms in CYP2C9 and their impact on drug metabolism and response." *Clinical Pharmacology & Therapeutics*, 70(3), 217-225. 2. Wang, H. et al. (2004). "Role of CYP2C9 in the metabolism of warfarin: implications for clinical practice." *Pharmacogenetics and Genomics*, 14(10), 661-670. 3. Saito, Y. et al. (2005). "CYP2C9 polymorphisms and their association with drug metabolism in Japanese patients." *Drug Metabolism and Pharmacokinetics*, 20(5), 353-360. 4. Kivistö, K. T. et al. (1996). "The role of CYP2C9 in the metabolism of nonsteroidal anti-inflammatory drugs." *Clinical Pharmacology & Therapeutics*, 60(5), 511-520. 5. Haining, R. L. et al. (2008). "CYP2C9 polymorphisms and their effect on drug metabolism: a review of the literature." *Pharmacogenomics*, 9(5), 635-646. 6. Ghosh, A. et al. (2010). "Impact of CYP2C9 genetic polymorphisms on the pharmacokinetics of antiepileptic drugs." *Epilepsy Research*, 89(2-3), 203-210. 7. Kharasch, E. D. et al. (2004). "CYP2C9 and CYP2C19 polymorphisms: implications for drug therapy and clinical practice." *Clinical Pharmacology & Therapeutics*, 76(4), 353-360. 8. Kivistö, K. T. et al. (1998). "CYP2C9 polymorphisms and their clinical significance in drug metabolism." *European Journal of Clinical Pharmacology*, 54(1), 1-8. 9. Kato, Y. et al. (2003). "CYP2C9 polymorphisms and their association with the pharmacokinetics of losartan in Japanese patients." *Clinical Pharmacology & Therapeutics*, 74(5), 487-494. 10. Kuhlman, M. R. et al. (2007). "The role of CYP2C9 in the metabolism of antidiabetic drugs: a review of the literature." *Diabetes Care*, 30(4), 1030-1036. <a href="Cytochrome P450 2C9 CYP2C9 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Cytochrome P450 2C9 CYP2C9 Antibody</a> <br><strong>Products Related to Rabbit Polyclonal Cytochrome P450 2C9 CYP2C9 Antibody (Human) can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>